Controlled Release 7-Methoxytacrine-Polycaprolactone Nanocapsules Drug-Delivery System for Alzheimer's Disease Treatment: Synthesis and Physico-Chemical Characterization
1.Department of Chemistry, Science and Research Branch, Islamic Azad University, Tehran, Iran ;2.Department of Science, Payame Noor University (PNU), PO Box: 19395-4697, Tehran, Iran ;
Abstract:
Journal of Polymers and the Environment - Alzheimer’s disease is the most prevalent cause of dementia in aging people. 7-Methoxytacrine (7-MEOTA) is one of the approved drugs for the...